| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biocenter Oulu (M.H., R.N., F.N., P.I., J.V., H.P., S.V.) and Departments of Biochemistry (M.H., H.P., S.V.), Physiology (J.L.), and Medical Biochemistry and Molecular Biology (R.P., F.N., P.I., S.V.), University of Oulu, FIN-90014 Oulu, Finland
Address all correspondence and requests for reprints to: Dr. Seppo Vainio, Department of Medical Biochemistry and Molecular Biology, University of Oulu, Aapistie 5A, University of Oulu, P.O. Box 5000, FIN-90014 Oulu, Finland. E-mail: seppo.vainio{at}oulu.fi.
Wnt-4 signaling has been implicated in female development, because its absence leads to partial female to male sex reversal in the mouse. Instead of Mullerian ducts, Wnt-4-deficient females have Wolffian ducts, suggesting a role for androgens in maintaining this single-sex duct type in females. We demonstrate here that testosterone is produced by the ovary of Wnt-4-deficient female embryos and is also detected in the embryonic plasma. Consistent with this, the expression of several genes encoding enzymes in the pathway leading to the synthesis of testosterone in the mouse is induced in the Wnt-4-deficient ovary, including Cyp11a, Cyp17, Hsd3b1, Hsd17b1, and Hsd17b3. Inhibition of androgen action with an antiandrogen, flutamide, during gestation leads to complete degeneration of the Wolffian ducts in 80% of the mutant females and degeneration of the cortical layer that resembles the tunica albuginea in the masculinized ovary. However, androgen action is not involved in the sexually dimorphic organization of endothelial cells in the Wnt-4 deficient ovary, because flutamide did not change the organization of the coelomic vessel. These data imply that Wnt-4 signaling normally acts to suppress testosterone biosynthesis in the female, and that testosterone is the putative mediator of the masculinization phenotype in Wnt-4-deficient females.
This article has been cited by other articles:
![]() |
G.-C. Wu and C.-F. Chang wnt4 Is Associated with the Development of Ovarian Tissue in the Protandrous Black Porgy, Acanthopagrus schlegeli Biol Reprod, December 1, 2009; 81(6): 1073 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Houmard, C. Small, L. Yang, T. Naluai-Cecchini, E. Cheng, T. Hassold, and M. Griswold Global Gene Expression in the Human Fetal Testis and Ovary Biol Reprod, August 1, 2009; 81(2): 438 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-F. Liu, N. Bingham, K. Parker, and H. H.-C. Yao Sex-specific roles of {beta}-catenin in mouse gonadal development Hum. Mol. Genet., February 1, 2009; 18(3): 405 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Manuylov, F. O. Smagulova, L. Leach, and S. G. Tevosian Ovarian development in mice requires the GATA4-FOG2 transcription complex Development, November 15, 2008; 135(22): 3731 - 3743. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tomizuka, K. Horikoshi, R. Kitada, Y. Sugawara, Y. Iba, A. Kojima, A. Yoshitome, K. Yamawaki, M. Amagai, A. Inoue, et al. R-spondin1 plays an essential role in ovarian development through positively regulating Wnt-4 signaling Hum. Mol. Genet., May 1, 2008; 17(9): 1278 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-A. Chassot, F. Ranc, E. P. Gregoire, H. L. Roepers-Gajadien, M. M. Taketo, G. Camerino, D. G. de Rooij, A. Schedl, and M.-C. Chaboissier Activation of {beta}-catenin signaling by Rspo1 controls differentiation of the mammalian ovary Hum. Mol. Genet., May 1, 2008; 17(9): 1264 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Philibert, A. Biason-Lauber, R. Rouzier, C. Pienkowski, F. Paris, D. Konrad, E. Schoenle, and C. Sultan Identification and Functional Analysis of a New WNT4 Gene Mutation among 28 Adolescent Girls with Primary Amenorrhea and Mullerian Duct Abnormalities: A French Collaborative Study J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 895 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ottolenghi, E. Pelosi, J. Tran, M. Colombino, E. Douglass, T. Nedorezov, A. Cao, A. Forabosco, and D. Schlessinger Loss of Wnt4 and Foxl2 leads to female-to-male sex reversal extending to germ cells Hum. Mol. Genet., December 1, 2007; 16(23): 2795 - 2804. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kurokawa, D. Saito, S. Nakamura, Y. Katoh-Fukui, K. Ohta, T. Baba, K.-i. Morohashi, and M. Tanaka Germ cells are essential for sexual dimorphism in the medaka gonad PNAS, October 23, 2007; 104(43): 16958 - 16963. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Taniguchi, J. F. Couse, K. F. Rodriguez, J. M. A. Emmen, D. Poirier, and K. S. Korach Estrogen receptor-{alpha} mediates an intraovarian negative feedback loop on thecal cell steroidogenesis via modulation of Cyp17a1 (cytochrome P450, steroid 17{alpha}-hydroxylase/17,20 lyase) expression FASEB J, February 1, 2007; 21(2): 586 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wilhelm, S. Palmer, and P. Koopman Sex Determination and Gonadal Development in Mammals Physiol Rev, January 1, 2007; 87(1): 1 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Corton, J. I. Botella-Carretero, A. Benguria, G. Villuendas, A. Zaballos, J. L. San Millan, H. F. Escobar-Morreale, and B. Peral Differential Gene Expression Profile in Omental Adipose Tissue in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 328 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Poutanen Toward understanding the endocrine regulation of gonadal somatic cells. Endocrinology, August 1, 2006; 147(8): 3662 - 3665. [Full Text] [PDF] |
||||
![]() |
J. F. Couse, M. M. Yates, K. F. Rodriguez, J. A. Johnson, D. Poirier, and K. S. Korach The Intraovarian Actions of Estrogen Receptor-{alpha} Are Necessary to Repress the Formation of Morphological and Functional Leydig-Like Cells in the Female Gonad Endocrinology, August 1, 2006; 147(8): 3666 - 3678. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chi, P. Itaranta, S. Zhang, and S. Vainio Sprouty2 Is Involved in Male Sex Organogenesis by Controlling Fibroblast Growth Factor 9-Induced Mesonephric Cell Migration to the Developing Testis Endocrinology, August 1, 2006; 147(8): 3777 - 3788. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |